Home | Clinical Care | Research | Training | Division Activities

Education and Training:

B.S., Biology, Summa Cum Laude, Loyola University, Chicago, IL (1969)

M.D., University of Chicago, School of Medicine, Chicago, IL (1973)

Internship, University of California, San Francisco, CA (1973-74)

Residency I & 2, University of California, San Francisco, CA (1974-76)

Fellowship, Hematology, University of Washington, Seattle, WA (1976-78)

John M. Harlan, M.D.
Professor of Medicine
Adjunct Professor of Pathology
University of Washington

Associate Medical Director for Blood Services
Chief, Section of Hematology/Oncology
Harborview Medical Center

Office Address:
Harborview Medical Center
Box 359756
Research & Training Building, Room 503c
300 Ninth Avenue
Seattle, WA 98104

Phone:  (206) 897-5314
Fax:      (206) 897-5312
E-mail:  jharlan@u.washington.edu

 

CURRENT CLINICAL INTERESTS

General hematology/oncology, thrombosis, hypercoagulability


CURRENT RESEARCH INTERESTS

Endothelial cell and leukocyte biology


RESEARCH DESCRIPTION

Inflammation and Vascular Biology. . Leukocyte adherence to endothelium is a critical event in host defense and repair, but may also contribute to the pathogenesis of vascular and tissue injury in inflammatory and immune disorders. Adhesive interactions between circulating leukocytes and the vessel wall involve a cascade of events beginning with low-affinity adhesion manifested by rolling under conditions of flow, subsequent firm adhesion, and finally diapedesis between endothelial cells (EC) and migration to the extravascular site of inflammation or immune reaction. Using cell and molecular biology techniques and gene-targeted mice, our current studies examine: 1) the regulation of leukocyte integrin receptor avidity by high-density ligand and cyclin-dependent kinases; and 2) the role of leukocyte VLA-4 integrin in the progression of advanced atherosclerosis in murine models.

Recent studies also examine the mechanisms and consequences of EC or leukocyte apoptosis during inflammatory ‘stress’. These studies involve in vitro investigation of the role of apoptotic signaling pathways in EC and leukocyte activation. Transgenic and gene-targeted mice are used to elucidate the contribution of apoptosis in disease models of atherosclerosis, ischemia-reperfusion injury, and sepsis.


SELECTED PUBLICATIONS

Iwata A, Nishio K, Winn RK, Chi EY, Henderson WR Jr., Harlan JM. A broad-spectrum caspase inhibitor attenuates allergic airway inflammation in murine asthma model. J. Immunol. 170: 3386-91, 2003.

Li X, Tupper J, Bannerman D, Rhodes C, Winn R, Harlan J.  Phosphoinositide 3 kinase mediates Toll-like receptor 4-induced activation of NF-kB in endothelial cells. Infection and Immunity 71:4414-4420, 2003.

Iwata A, Morgan-Stevenson V, Minard A, Tasch M, Tupper J, Lagasse E, Weissman, Harlan J, Winn R.  Over-expression of Bcl-2 provides protection in septic mice by a ‘trans’ effect. J. Immunol. 171(6):3136-41, 2003.

Bannerman DD, Eiting KT, Winn RK, Harlan JM.  FLICE-like inhibitory protein (FLIP) protects against apoptosis and suppresses NF-kappaB activation induced by bacterial lipopolysaccharide.  Am. J. Pathol. 165:1423-31,  2004.

Vanasse GJ, Winn RK, Rodov S, Zieske AW, Li JT, Tupper JC, Tang J, Raines EW, Peters MA, Yeung KY, Harlan JM.  Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma. Mol. Cancer Res. 2:620-31, 2005.

Altemeier, W, Zhu  X, Berrington W, Harlan J, Liles WC.  Fas (CD95) induces macrophage pro-Inflammatory chemokine expression via a MyD88-dependent, Caspase-independent pathway. J. Leuk. Biol. 82(3):721-8, 2007.

Taylor EL, Li JT, Tupper JC, Rossi AG, Winn RK, Harlan JM.  Peroxynitrite induces Bcl-2-sensitive, p53-independent apoptosis in murine bone marrow cells.  Biochem. Pharmacol. 74(7):1039-49, 2007.

L Liu, Schwartz B, Tsubota Y, Raines E, Yonekawa K, Harlan J (co-senior author), Schnapp L.  Cyclin-dependent kinase inhibitors block leukocyte adhesion and migration. J. Immunol. 180(3):1808-17, 2008.

Helmers AJ, Lovegrove FE, Harlan JM, Kain KC, Liles WC.  Failure of two distinct anti-apoptotic approaches to reduce mortality in experimental cerebral malaria. Am .J. Trop. Med. Hyg. 79(6):823-5, 2008.

Becker PS, Kopecky KJ, Wilks AN, Chien S, Harlan JM, Willman CL, Petersdorf SH, Stirewalt DL, Papayannopoulou T, Appelbaum FR. Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia. Blood  113(4):866-74, 2009.